Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10240-1 | AS-252424 | LSM-4263 |  | 56965900 | |
| 10345-3 | Torkinib | PP242 | LSM-6357 |  | 57347681 |
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10133-2 | Afatinib | BIBW-2992 | LSM-43226 |  | 57519523 |
| 10278-1 | Topotecan | Hycamtin | LSM-5662 |  | 60700 |
| 10252-1 | Gemcitabine | Gemzar | LSM-5333 |  | 60750 |
| 10246-1 | CPT-11 | Irinotecan | LSM-2167 |  | 60838 |
| 10513-1 | Nelfinavir | Viracept |  | 64143 | |
| 10099-2 | Nilotinib | AMN-107 | LSM-1099 |  | 644241 |
| 10108-2 | Geldanamycin | LSM-42789 |  | 644250 | |
| 10280-1 | Triciribine | LSM-3810 |  | 65399 | |
| 10260-1 | Ispinesib | SB-715992 | LSM-5732 |  | 6851740 |
| 10257-1 | GSK923295 | LSM-4278 |  | 68651179 | |
| 10048-6 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10048-7 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10502-1 | Bromopyruvic acid | 3-bromopyruvic acid; Bromopyruvate |  | 70684 | |
| 10251-1 | Fascaplysin | LSM-4272 |  | 73293 | |
| 10208-2 | JNK-IN-5A | TCS JNK 5a; KIN001-188 | LSM-1209 |  | 766949 |
| 10512-1 | Methylglyoxal | Acetylformaldehyde; Pyruvaldehyde |  | 880 | |
| 10501-1 | 2-deoxyglucose | 2-deoxy-D-glucose; 2-Desoxy-D-glucose; 2-DG |  | 9062 | |
| 10228-2 | IKK16 | LSM-2309 |  | 9549298 | |
| 10014-3 | GW843682X | GW843682 | LSM-1014 |  | 9826308 |
| 10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 |  | 9868928 |
| 10274-1 | SB-3CT | LSM-4293 |  | 9883002 | |
| 10136-2 | TPCA-1 | LSM-1136 |  | 9903786 |